Early Access — free while we kick the tires
EdgarHawk

PAUL STEVEN M

Director

Director
1 filing analyzed · 1 company · Latest 2025-09-15

Companies

Company Buys Sells Direction
Rapport Therapeutics, Inc. RAPP 2 0 Net buying

Activity

September 2025
high
Buy
41,666 shares
$1,027,111
Significance 7/10

Director Paul Steven M purchases 41,666 shares at avg $24.65 in 2 transactions; cluster buy pattern as 2 other insiders bought within 14 days.

Director Paul Steven M executed two open-market purchases totaling 41,666 shares for $1,027,111.29 on 2025-09-12, establishing a new position at a blended average price of $24.65. The stock is currently trading at $24.73, near the transaction price, after a 30-day climb of +68.2% and 90-day surge of +125.8%. This buy occurs within a cluster pattern: 2 other insiders also purchased shares within the past 14 days. The company reported negative net income of $-26,732,000.00 over its most recent full fiscal year and carries a market cap of $902.6M. The coordinated accumulation by multiple insiders amid unprofitability and recent sharp price appreciation warrants investor attention to both the motivation behind these concurrent transactions and the company's cash burn trajectory.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access